Cardiovascular Systems PT Raised to $35.00 at Benchmark Co. (CSII)
Benchmark Co. increased their target price on shares of Cardiovascular Systems (NASDAQ:CSII) to $35.00 in a research note issued on Tuesday, AmericanBankingNews.com reports. Benchmark Co.’s price target suggests a potential upside of 53.98% from the company’s current price.
Shares of Cardiovascular Systems (NASDAQ:CSII) traded up 18.13% on Tuesday, hitting $26.85. The stock had a trading volume of 1,267,225 shares. Cardiovascular Systems has a 1-year low of $10.38 and a 1-year high of $23.75. The stock’s 50-day moving average is $20.81 and its 200-day moving average is $20.24. The company’s market cap is $668.7 million.
Cardiovascular Systems (NASDAQ:CSII) last announced its earnings results on Wednesday, August 7th. The company reported ($0.28) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.30) by $0.02. The company had revenue of $28.80 million for the quarter, compared to the consensus estimate of $27.18 million. Analysts expect that Cardiovascular Systems will post $-1.14 EPS for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Wunderlich raised their price target on shares of Cardiovascular Systems from $24.00 to $30.00 in a research note to investors on Tuesday. They now have a “buy” rating on the stock. Separately, analysts at Feltl & Co. upgraded shares of Cardiovascular Systems from a “buy” rating to a “strong-buy” rating in a research note to investors on Thursday, August 8th. They now have a $27.50 price target on the stock, up previously from $19.50. Three analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Cardiovascular Systems currently has an average rating of “Buy” and an average target price of $29.30.
In other Cardiovascular Systems news, VP Kevin J. Kenny sold 4,182 shares of Cardiovascular Systems stock on the open market in a transaction dated Wednesday, October 16th. The stock was sold at an average price of $22.95, for a total transaction of $95,976.90. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.